Global Immuno Oncology Assays Market 2019 by Company, Regions, Type and Application, Forecast to 2024

SKU ID : GIR-GIR1902180004 13920269

Publishing Date : 11-Sep-2019

No. of pages : 104


  • Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

    Scope of the Report:
    The global Immuno Oncology Assays market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
    The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
    North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Immuno Oncology Assays.
    Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
    This report studies the Immuno Oncology Assays market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Immuno Oncology Assays market by product type and applications/end industries.

    Market Segment by Companies, this report covers
    Thermo Fischer Scientific
    Roche Diagnostics
    Agilent Technologies

    Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

    Market Segment by Type, covers
    Flow Cytometry
    Next Generation Sequencing

    Market Segment by Applications, can be divided into
    Clinical Diagnostics